Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8586
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBudiarti, Retno-
dc.contributor.authorEdiono, Ediono-
dc.contributor.authorMiftahussurur, Muhammad-
dc.date.accessioned2024-11-29T03:49:14Z-
dc.date.available2024-11-29T03:49:14Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8586-
dc.description.abstractObjective: This study aimed to compare the most useful biomarkers for predicting prognosis and response to therapy in COVID-19 patients. Material and Methods: This quantitative study involved 639 patients who were hospitalized with COVID-19 infection. Patients without any biochemical marker result; patients referred to another hospital; and peripheral oxygen levels measured using oxygen supplementation were excluded from the study. Results: There was a statistically significant difference in terms of demographics, vital signs on admission, and laboratory parameters. The risk of mortality in COVID-19 is significantly influenced by c-reactive protein (CRP) and interleukin-6 (IL-6) levels (p-value <0.05). Conclusion: Findings revealed these biomarkers could help the future development of more personalized treatment and diagnostic approaches. Keywords: Biomarker, COVID-19, Outcome.en_US
dc.subjectBiomarker, COVID-19, Outcome.en_US
dc.titleBiomarker Profiles Associated with Covid-19 Mortality in East Java, Indonesia: A Tertiary Care Hospital Studyen_US
dc.typeArticleen_US
Appears in Collections:VOL 16 NO 3 2024

Files in This Item:
File Description SizeFormat 
29.pdf299.24 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.